Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 9673537, 21 pages
https://doi.org/10.1155/2017/9673537
Review Article

Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation

1Verra Therapeutics, 127 Asbury Rd., Lansing, NY 14882, USA
2Rumbaugh-Goodwin Institute for Cancer Research, Nova Southeastern University, 3321 College Avenue, CCR 6th Floor, Fort Lauderdale, FL 33328, USA
3College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, FL 33328, USA

Correspondence should be addressed to Marcia L. Moss

Received 4 July 2017; Revised 15 August 2017; Accepted 11 September 2017; Published 2 November 2017

Academic Editor: Vera L. Petricevich

Copyright © 2017 Marcia L. Moss and Dmitry Minond. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Marcia L. Moss and Dmitry Minond, “Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation,” Mediators of Inflammation, vol. 2017, Article ID 9673537, 21 pages, 2017. doi:10.1155/2017/9673537